Introducing Wedgewood Connect

Wedgewood Connect

As a partner in patient care, Wedgewood Pharmacy is dedicated to elevating your access to high-quality medications. In our ongoing efforts to deliver new and innovative solutions to meet your needs, we are excited to introduce Wedgewood Connect, our new, FDA-registered, 503B Outsourcing Facility.

Elevated Access to Office-Use Medications

A 503B Outsourcing Facility is a designation that was created by Congress in the Drug Quality & Security Act to bridge the gap between traditional state-licensed compounding pharmacies and industrial pharmaceutical manufacturers. 503B Outsourcing Facilities must register with FDA and adhere to cGMP (Current Good Manufacturing Practices) standards. 503B Outsourcing Facilities provide access to compounded medications for office use, enabling you to begin treatment as soon as possible.

Offering the combined formularies of both a traditional state-licensed compounding pharmacy and 503B Outsourcing Facility allows us to provide a full spectrum of high-quality medications, ranging from highly customized compounded medications for patient-specific prescriptions to office-use items you always need on your shelf.

Unified Ordering

Our approach to this combined offering is simple: you tell us exactly what you need, and we will get it to you or your patient as quickly, easily, and affordably as possible.

You can continue to access our entire formulary, including those prepared at Wedgewood Connect, through our Customer Care team at 800-216-5005, or by fax at 800-589-4250.

About 503B Outsourcing Facilities

  • Adhere to current Good Manufacturing Practices (cGMP)
  • Quality built into every step of the development and compounding process
  • State-of-the-art facilities ensure high-quality office-use medications
  • Expertly maintained and calibrated equipment
  • Fully trained and qualified employees
  • Products that are exhaustively studied
  • Reliable and reproducible processes

Available Products

Select formulations of sterile Ophthalmic solutions of Cyclosporine and Tacrolimus will be introduced weekly between December 1, 2020 and December 31, 2020. We are dedicated to continuous innovation and look forward to expanding our 503B formulary to include more of the medications your practice and patients rely on.

Wedgewood Connect Product
  • Cyclosporine in Corn Oil 0.2% Ophthalmic Solution 15ml
  • Cyclosporine in Corn Oil 1% Ophthalmic Solution 15ml
  • Cyclosporine in Corn Oil 2% Ophthalmic Solution 15ml
  • Cyclosporine in MCT Oil 1% Ophthalmic Solution 15ml
  • Cyclosporine in MCT Oil 2% Ophthalmic Solution 15ml
  • Tacrolimus in Corn Oil 0.02% Ophthalmic Solution 15ml
  • Tacrolimus in Corn Oil 0.03% Ophthalmic Solution 15ml
  • Tacrolimus in MCT Oil 0.02% Ophthalmic Solution 15ml
  • Tacrolimus in MCT Oil 0.03% Ophthalmic Solution 15ml

State Licenses

Wedgewood Connect is currently licensed as an 503B Outsourcing Facility in the states indicated below. If Wedgewood Connect is not yet licensed in your state, rest assured that medications will still be available through Wedgewood Pharmacy.

State Licenses